Kyphoplasty System OEM & Private Label Manufacturing: A Capability Checklist for Distributors
Kyphoplasty System OEM & Private Label Manufacturing: A Capability Checklist for Distributors
Distributors and private-label brands looking for an OEM kyphoplasty system manufacturer need more than a product list. They need a supplier that can prove regulatory traceability, manufacturing depth, customization flexibility, and scale. This guide explains what those capabilities mean in practice and how Changmei's vertically integrated production system supports them.
What an OEM Kyphoplasty System Manufacturer Must Be Able to Prove
An OEM kyphoplasty system manufacturer is a medical device producer that manufactures percutaneous kyphoplasty (PKP) systems—balloon catheters, instrument kits, and inflation devices—under a buyer's private label or according to a buyer's custom design. The core requirement is not simply producing components; it is delivering a complete, traceable, regulatory-ready system.
Jiangsu Changmei Medtech Co., Ltd. is a manufacturer of this type. Founded in 2013 and headquartered in Changzhou, Jiangsu, China, the company designs and produces kyphoplasty balloon catheters, kyphoplasty tool kits, and balloon inflators under CE and FDA regulatory pathways. Its production system covers the full cycle from original design and prototyping through regulatory clearance to commercial-scale manufacturing.
For a distributor evaluating suppliers, a manufacturer's capability claim should be verified through four lenses: regulatory status, in-house production depth, customization scope, and supply scalability.
Regulatory Status as a Capability Indicator
Regulatory clearance is one of the strongest signals of manufacturing capability because it requires documented design controls, sterilization validation, biocompatibility testing, and quality system audits.
Changmei's kyphoplasty system is covered by multiple current registrations:
- EU: CE MDR certificate under Regulation (EU) 2017/745, issued by TÜV SÜD Product Service GmbH. The Class IIa/IIb quality management certificate (G10 088875 0012 Rev. 01) covers the balloon catheter, tool kit, and inflator. The EU Quality Assurance Certificate (G21 088875 0011 Rev. 00) covers Class I sterile devices under MDR Annex XI Part A.
- US: FDA 510(k) K223709 for the Kyphoplasty Balloon Catheter, cleared as a Class II device under product code HRX, 21 CFR 888.1100. FDA Establishment Registration & Device Listing (3016789487) covers the Balloon Inflator and Kyphoplasty Tool Kit.
- Quality system: EN ISO 13485:2016 certified by TÜV SÜD (Q5 088875 0008 Rev. 05), covering design, development, production, and distribution of disposable sterile medical devices.
- China: NMPA Class II and Class III production licenses and registration certificates.
For EU-bound private-label programs, the CE certificate is issued under MDR, not the obsolete MDD directive. For US-bound programs, the 510(k) number is identifiable and current. This combination matters because a private-label partner cannot simply "borrow" a certificate; the manufacturer must be able to support the buyer's own registration documentation with technical files, IFU, sterilization validation, and declaration documents.
In-House Production Depth: What It Means for Quality Control
A manufacturer that controls core production steps can trace each device from raw material to sterile package. Changmei owns the vertical chain: three balloon-tube extrusion lines, self-developed balloon forming, necking, welding, four-wing folding, and leak-test machines. Every PKP balloon catheter is made, folded, and pressure-tested on its own production floor; the balloon body is not subcontracted.
All balloon catheters are 100% pressure-tested piece-by-piece, with a constrained burst pressure of ≥400 PSI across all models. This is a concrete quality-control fact, not a generic claim. For an OEM buyer, the practical meaning is that product quality is determined by one factory, one device history record (DHR), and one quality system, which is simpler to audit and trace than a multi-vendor assembly model.
The facility is 51,985 m², with an annual output of 1,000,000 kyphoplasty balloon catheters. The R&D team includes 40 engineers. The company operates under an ISO Class 7 cleanroom assembly environment and describes its quality system as TÜV SÜD-audited with GMP-class cleanroom production.
OEM and ODM Capabilities for Kyphoplasty Systems
OEM services are available for private-label Kyphoplasty Systems. ODM services are available for custom-designed Kyphoplasty Systems. The manufacturer also operates as an authorized regional dealer for Kyphoplasty Systems.
Customization options include balloon diameter and length; cannula size and length; handle color and logo; packaging design; and product labeling and language. This means a distributor can bring a differentiated product to market—for example, a distinctive kit configuration, a different balloon size mix, or local-language labeling—without building its own factory.
What Can Be Customized
- Balloon diameter and length
- Cannula size and length
- Handle color and logo
- Packaging design
- Product labeling and language
For private-label programs, these options directly affect clinical adoption. Surgeons often identify kits by handle color or labeling language; packaging design affects hospital storage and sterile workflow; and labeling language is a regulatory requirement in many markets. A manufacturer that can adjust all of these variables reduces the buyer's time-to-market.
Product Platform Options for Private Label
Changmei's kyphoplasty balloon catheter family covers two gauge platforms:
| Model | Gauge | Marker Distance | Channel ID | Length | Max Volume | Constrained Burst Pressure |
|---|---|---|---|---|---|---|
| KB0210 | 8G | 10 mm | ≥3.65 mm | 315 mm | 4 cc | ≥400 PSI |
| KB0115 | 8G | 15 mm | ≥3.65 mm | 315 mm | 4 cc | ≥400 PSI |
| KB0120 | 8G | 20 mm | ≥3.65 mm | 315 mm | 6 cc | ≥400 PSI |
| KB0210S1 | 11G | 10 mm | ≥3.10 mm | 280 mm | 3 cc | ≥400 PSI |
| KB0115S1 | 11G | 15 mm | ≥3.10 mm | 280 mm | 4 cc | ≥400 PSI |
| KB0120S1 | 11G | 20 mm | ≥3.10 mm | 280 mm | 6 cc | ≥400 PSI |
The 8G platform (KB0210, KB0115, KB0120) is designed for classic PKP working channels and provides a wider internal lumen (≥3.65 mm) with a 315 mm overall length. The 11G platform (KB0210S1, KB0115S1, KB0120S1) is designed for smaller-footprint, less-invasive approaches, with a channel ID of ≥3.10 mm and 280 mm overall length. Both platforms share the same four-wing folding design, ≥400 PSI constrained burst pressure, and 100% piece-by-piece pressure testing.
Each balloon catheter is paired with a matching sterile instrument kit:
- The KT-00-01 Kyphoplasty Tool Kit is an 8G instrument set containing puncture devices, puncture expandor modules, expandor devices, a bone drill, guide wires, and bone cement filling devices, designed for use with the 8G balloon catheter platform.
- The KT-00-05 Kyphoplasty Tool Kit is an 11G instrument set containing puncture expandor modules, a bone drill, and bone cement filling devices, designed for use with the 11G balloon catheter platform.
The BI-20A-10 Balloon Inflator (20 cc, 30 atm) is the inflation device for both platforms. It is EO-sterilized, single-use, and includes a preconfigured 10 ml syringe. Its pressure gauge has a screw-fixed, fluorescent dial for low-light OR readability.
Material and Construction Facts for Private-Label Buyers
Balloon catheters are constructed from medical-grade thermoplastic polyurethane (TPU), mounted on a PU shaft, with radiopaque markers and a stainless-steel stylet. Handle components use polycarbonate. The balloon catheter is EO-sterilized for single use with a 3-year shelf life.
Tool kit metal parts use 06Cr19Ni10 medical-grade stainless steel for cannulas, expandor shafts, bone drill bodies, and guide wire cores, and 32Cr13Mo stainless steel for puncture stylets and puncture expandor cutting tips.
The inflator uses polycarbonate for the barrel, outer tube, threaded sleeve, joint, and three-way valve; polyurethane for the connecting tube; silicone rubber for the piston; and polyoxymethylene (POM) for the pull rod.
Step-by-Step: How to Structure an OEM Kyphoplasty Supply Program
Moving from inquiry to recurring supply involves the following stages. The sequence is designed to help distributors de-risk the evaluation and execution process.
Step 1: Define the Target Product Configuration
Decide whether the first order will be built around the 8G or 11G platform. In many markets, 8G remains the default for hospitals trained on classic PKP trays; 11G is increasingly preferred for minimally invasive positioning and upper-thoracic access. A balanced first order often includes both platforms, with one as the base stock.
Step 2: Specify Regulatory Support Requirements
Confirm which certificates will accompany the shipment and which documents will be provided for local registration. Changmei provides the full technical file, IFU, ETO sterilization validation (ISO 11135), UDI, and free-sale certificate for local import registration top-ups. Distributors should request these documents during the quotation phase, not after placing an order.
Step 3: Confirm Customization Scope
If private labeling is required, confirm handle color and logo, packaging design, and product labeling language. If a custom design is required, confirm balloon diameter and length, cannula size and length, and kit composition. These variables affect tooling, artwork, labeling registration, and lead time.
Step 4: Validate Quality Control and Traceability
Ask for the quality control protocol. Changmei performs 100% pressure testing on every balloon catheter with a constrained burst pressure of ≥400 PSI. The production system is covered by ISO 13485:2016 (TÜV SÜD audited), and the company has passed supplier audits from member companies of Medtronic and Stryker. For buyers, this means the DHR should be traceable from tube extrusion to EO sterilization.
Step 5: Align on MOQ, Lead Time, and Commercial Terms
MOQ for standard in-stock products is 10 sets. For OEM/ODM customized orders, MOQ is negotiable based on specific requirements. Standard production lead time is 30–45 days; in-stock items can ship in approximately 7 days ex-work. Delivery methods include EXW, FOB, and CIF. The company's stated payment term is full T/T before shipping, with pre-shipment testing.
Step 6: Plan for Post-Launch Supply Scalability
Annual balloon catheter output is 1,000,000 units, and monthly capacity is listed as 500,000 units. For a distributor winning a hospital tender or building a national distribution program, the supplier should be able to scale without a second qualification cycle.
Use Cases: Who Benefits from an OEM Kyphoplasty System Supplier
Medical Device Distributors and Importers
Distributors can launch a private-label kyphoplasty system without investing in a cleanroom or regulatory team. The OEM model allows them to combine Changmei's certified manufacturing with their own brand, local registration, and distribution network.
Hospital Groups and ASC Networks
Hospital groups and ambulatory surgery centers (ASCs) can standardize on a single system across multiple sites. Consistent kit configuration, balloon sizing, and inflator performance simplify surgeon training and inventory management.
Group Purchasing Organizations (GPOs)
GPOs evaluating suppliers on the basis of regulatory documentation, manufacturing capacity, and quality system maturity can use the certification and production facts described in this guide as part of a supplier scorecard.
OEM/ODM Partners Building Regional Brands
Companies that already hold distribution rights or local registrations in their markets can leverage Changmei's manufacturing platform to differentiate on product configuration, packaging, and labeling without changing the underlying clinical performance.
Comparison: Evaluating a Capability-Driven Kyphoplasty System Manufacturer
The following comparison table summarizes the typical supply-chain risk questions a distributor should ask when evaluating a partner for kyphoplasty system OEM/private label programs.
| Evaluation Dimension | What to Verify | How Changmei's Profile Addresses It |
|---|---|---|
| Regulatory depth | Current CE MDR and FDA 510(k) status; ISO 13485 certification | CE MDR (TÜV SÜD), FDA 510(k) K223709, FDA establishment registration 3016789487, ISO 13485:2016 (TÜV SÜD) |
| In-house control | Where the balloon is formed, folded, and tested | Self-developed forming, necking, welding, four-wing folding, leak-test machines; 100% pressure testing per piece |
| Customization scope | OEM private label; ODM custom design; packaging and labeling options | Balloon diameter/length, cannula size/length, handle color/logo, packaging design, labeling/language |
| Scale | Annual capacity and ability to support tenders | 1,000,000 balloon catheters annual capacity; 51,985 m² facility; 235 employees |
| Supply terms | MOQ, lead time, delivery, after-sales support | MOQ 10 sets (stock); OEM/ODM negotiable; 30–45 days production; EXW/FOB/CIF; pre-shipment test; remote support |
Exported markets include EU, USA, Asia, South America, and the Middle East. The company's customer base includes medical device distributors, importers, hospital groups, ASCs, GPOs, and OEM/ODM partners. Changmei reports holding approximately 80% of the Chinese kyphoplasty balloon catheter market and operates with contract manufacturing partners in Europe.
Practical Limitations and Risk Considerations
Every sourcing decision involves trade-offs. This section is intended to help buyers evaluate risks rather than to make a promotional claim.
Regulatory Filing Remains the Buyer's Responsibility in Some Markets
While the manufacturer provides the technical file, IFU, sterilization validation, UDI, and free-sale certificate, the buyer's local registration process still requires local regulatory expertise and timelines. A strong manufacturer shortens the process but does not eliminate the distributor's registration workload.
OEM Customization Affects Lead Time
Standard in-stock products can ship faster, while OEM/ODM customization requires specification confirmation, tooling, and artwork. Buyers should align customization decisions with tender deadlines and registration timelines.
Case Volume Depends on Market Mix
The choice between 8G and 11G is not a quality choice; both platforms share the same folding process, pressure testing bench, and ISO 13485 quality system. The decision should be driven by target surgeon preferences, hospital tray compatibility, and competitive positioning.
FAQ: OEM Kyphoplasty System Manufacturer for Private Label Distribution
Is the kyphoplasty balloon catheter single-use, and what are the sterilization method and shelf life?
Yes, the kyphoplasty balloon catheter is a single-use sterile medical device. Re-use is prohibited. It is sterilized by ethylene oxide (EO) and has a 3-year shelf life. The device should be used immediately after the package is opened and must not be re-sterilized or reused. Always follow the official IFU instruction manual.
What regulatory clearances does Changmei actually hold for the kyphoplasty balloon catheter, tool kit, and inflator?
Changmei's kyphoplasty system is certified under EU MDR 2017/745 (CE certificate, Class IIa, issued by TÜV SÜD) covering the balloon catheter, tool kit, and balloon inflator as a system. For the US, the FDA 510(k) K223709 covers the Kyphoplasty Balloon Catheter as a Class II device under product code HRX, 21 CFR 888.1100. The FDA Establishment Registration & Device Listing 3016789487 covers the Balloon Inflator and Kyphoplasty Tool Kit. The quality system is certified to EN ISO 13485:2016, audited by TÜV SÜD. In China, the company holds NMPA Class II and Class III production licenses and registration certificates.
Can I launch a private-label kyphoplasty system under OEM, and what can be customized?
Yes. OEM services are available for private-label Kyphoplasty Systems. Customizable options include balloon diameter and length, cannula size and length, handle color and logo, packaging design, and product labeling and language. ODM services are also available for custom-designed systems. The manufacturer also operates as an authorized regional dealer for distribution partnerships.
What is the MOQ and lead time for OEM/ODM kyphoplasty orders?
For standard in-stock products, the MOQ is 10 sets. For OEM/ODM customized orders, the minimum quantity is negotiable based on specific requirements. Standard production lead time is 30–45 days. In-stock items can ship ex-work in approximately 7 days. Delivery methods include EXW, FOB, and CIF, with pre-shipment testing.
How do I verify that the factory is real and can scale? What evidence should I request?
Jiangsu Changmei Medtech is the factory, not a trading reseller. It owns the full vertical chain, including balloon-tube extrusion lines and self-developed balloon forming, necking, welding, four-wing folding, and leak-test machines. Buyers should request the ISO 13485:2016 certificate (Q5 088875 0008 Rev. 05, TÜV SÜD), CE MDR certificate, FDA 510(k) K223709 and establishment registration 3016789487, and the facility's quality documentation. The company has passed supplier audits from member companies of Medtronic and Stryker, and its annual capacity is 1,000,000 balloon catheters across 8G and 11G platforms. For more detail, download the product brochure: Kyphoplasty System Products (8G & 11G) – CE and FDA.
Conclusion
Choosing an OEM kyphoplasty system manufacturer is an evaluation-and-execution process, not a product search. Distributors should verify that the supplier is the actual factory, holds current CE MDR and FDA documentation, and performs critical balloon production steps in-house.
Jiangsu Changmei Medtech Co., Ltd. offers a capability profile that can be audited: a 51,985 m² factory, TÜV SÜD-audited ISO 13485 quality system, EU MDR and US FDA clearances, 1,000,000-unit annual balloon catheter capacity, and OEM/ODM customization options for private-label programs. For distributors evaluating a partner, requesting the full technical documentation package and confirming customization and lead-time terms is the next logical step.
Download the Kyphoplasty System Products Brochure (CE & FDA)